Pan-PI3K inhibitors such as BKM120, BAY80-6946, and PI3K subunit selective inhibitors such as BYL719 and TAK117 showed sound anti-tumor effects in in vitro experiments of GC [78–83]. Here, PIK3CG is linked to gastric cancer.